3 completed. 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 3 | Completed 3 |
Follow Michael Graham PhD, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer Ga-68 PSMA-HBED-CC PET - Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant | Phase 2 / Phase 3 | Completed | Michael Graham PhD, MD | 6 | 2019-03-01 | 2025-04-17 |
| 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer Ga-68 PSMA-HBED-CC PET - Prostate Cancer, Prostatic Neoplasm | Phase 2 / Phase 3 | Completed | Michael Graham PhD, MD | 30 | 2018-02-16 | 2024-07-12 |
| 68Ga PSMA in Preprostatectomy Patients Ga-68 PSMA-HBED-CC PET - Prostate Cancer, Prostatic Neoplasm | Phase 2 / Phase 3 | Completed | Michael Graham PhD, MD | 22 | 2018-02-16 | 2024-02-15 |
Prostatic Neoplasms (3) · Prostatic Neoplasms, Castration-Resistant (3)
United States (3)
Michael Graham, MD, PhD (1) · Michael M Graham, Ph.D., MD (1) · Michael M. Graham, MD, PhD (1)